The U.S. FDA granted breakthrough device designation to Mursla Bio Ltd.'s Evoliver. The biopsy blood test uses extracellular vesicles to survey hepatocellular carcinoma in high-risk cirrhotic patients ...

A 54-year-old man in Delhi suffered injuries after he was allegedly thrashed by a young man on Thursday afternoon for ...

US FDA grants Breakthrough Device Designation to Mursla Bio’s EvoLiver test: Cambridge, UK Friday, April 25, 2025, 17:00 Hrs [IST] Mursla Bio, a leader in Extracellular Vesicle ...

Ipsen’s elafibranor has shown promise as a treatment for primary sclerosing cholangitis (PSC), a rare liver disease that ...

Multi-modal data integration of single-nuclei RNA and ATAC sequencing with spatial transcriptomics, provides new molecular insights into gene regulatory networks driving cell state transitions in ...

Symptoms, and Treatment Liver cancer is one of the most challenging forms of cancer, often developing quietly before showing any clear signs. It begins when abnormal cells form in the liver, a vital ...

A drug and alcohol service in Leeds has said it has "micro-eliminated" hepatitis C - meaning it has identified, treated and ...

Shubhangi Atre’s ex-husband, Piyush Poorey, passed away recently after a prolonged battle with liver cirrhosis, leaving many ...

From turmeric fears to water detox delusions, leading gastroenterologist Dr Gourdas Choudhuri clears the air on widespread ...

EvoLiver, a blood test that detects early-stage liver cancer with high accuracy, has gained breakthrough device designation from the FDA.

A devoted wife and mother, the woman tragically lost her life in a road accident. Yet, in a remarkable act of generosity, her ...

The future of treating metabolic dysfunction–associated steatohepatitis (MASH) looks brighter than ever, says Naim Alkhouri, MD, as data emerges on newly developed interventions.